Parameter | Beta coefficient | Standard error | Odds ratio (95Â % CI) | p value |
---|---|---|---|---|
Univariate logistic regression | ||||
 Age | 0.024 | 0.008 | 1.024 (1.010-1.040) | 0.001* |
 Female gender | −0.148 | 0.257 | 0.862 (0.522-1.426) | 0.564 |
 APACHEI II score | 0.066 | 0.019 | 1.068 (1.029-1.108) | <0.001* |
 SOFA score | 0.223 | 0.039 | 1.249 (1.157-1.349) | <0.001* |
 MOD score | 0.175 | 0.041 | 1.191 (1.099-1.291) | <0.001* |
 PaO2/FiO2 | −0.001 | 0.002 | 0.999 (0.996-1.003) | 0.683 |
 CCI | 0.161 | 0.055 | 1.174(1.055-1.307) | 0.003* |
 Moderate to severe liver disease | 0.553 | 0.359 | 1.739 (0.860-3.516) | 0.124 |
 Metastatic solid tumor | 0.929 | 0.415 | 2.532 (1.124-5.708) | 0.025* |
 Community-acquired ARDS | −0.879 | 0.279 | 0.415(0.240-0.718) | 0.002* |
Multivariate logistic regression | ||||
 Age | 0.037 | 0.009 | 1.038 (1.020-1.056) | <0.001* |
 SOFA score | 0.252 | 0.043 | 1.287 (1.184-1.399) | <0.001* |
 Metastatic solid tumor | 0.751 | 0.448 | 2.120 (0.881-5.099) | 0.093 |
 Community-acquired ARDS | −0.771 | 0.313 | 0.463 (0.250-0.855) | 0.014* |
 Constant | −4.400 | 0.814 | 0.012 | <0.001* |